Study summary

Phase IIIb, Open-label, randomized, controlled multi-centre study. Induction therapy phase for 6 months where all subjects receive 2 ELIGARD depot injections. Those subjects with hormone responsive prostate cancer will be randomized and will receive either intermittent or continuous ELIGARD treatment for 36 months. Following this treatment period, subjects will enter a long-term follow-up period for 48 months.

Additional Study Details

Phase
Phase 3
Product
N/A
Product
leuprorelin acetate
Type
Interventional
Masking
None (Open Label)
Enrollment number
706
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A phase IIIb study of intermittent versus continuous hormone deprivation treatment with ELIGARD? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Bruxelles, Belgium, 1200
    Completed
    Liege, Belgium, 4000
    Completed
    Brussel, Belgium
    Completed
    Bruxelles, Belgium, 1070
    Completed
    Leuven, Belgium, B-3000
    Completed
    Bmo, Czech Republic, 65691
    Completed
    Jablonec nad Nisou, Czech Republic, 46660
    Completed
    Olomouc, Czech Republic, 7521
    Completed
    Usti nad Labem, Czech Republic, 40113
    Completed
    Tampere, Finland, FIN-33521
    Completed
    Joensuu, Finland, FIN-80210
    Completed
    Paris, France, 75007
    Completed
    Toulon, France, 83000
    Completed
    Bordeaux, France, 33073
    Completed
    Paris, France, 94275
    Completed
    Caen-Cedex, France, 14033
    Completed
    Suresnes, France, 92151
    Completed
    Nantes, France, 44093
    Completed
    Cergy-Pontoise, France, 95301
    Completed
    Avignon, France, 84000
    Completed
    Ploemeur, France, 53275
    Completed
    Brest, France, 29609
    Completed
    Pierre-Benite, France, 69310
    Completed
    Rouen, France, 76031
    Completed
    Paris, France, 75014
    Completed
    Grenoble, France, 38043
    Completed
    Marseille, France, 13915
    Completed
    Toulouse, France, 31054
    Completed
    Hagenow, Germany, 19230
    Completed
    Neustadt i. Sachsen, Germany, 01844
    Completed
    Dresden, Germany, 01324
    Completed
    Bautzen, Germany, 02625
    Completed
    Trier, Germany, 54290
    Completed
    Bad Neuenaher, Germany, 53474
    Completed
    Hettstedt, Germany, 06333
    Completed
    Halle/Saale, Germany, 06132
    Completed
    Leipzig, Germany, 04105
    Completed
    Dresden, Germany, 01307
    Completed
    Szolnok, Hungary, 5000
    Completed
    Veszprem, Hungary, 8200
    Completed
    Nyiregyhaza, Hungary, 4400
    Completed
    Budapest, Hungary, 1106
    Completed
    Tatabanya, Hungary, 2800
    Completed
    Kaposvar, Hungary, 7400
    Completed
    Roma, Roma, Italy, 00189
    Completed
    Desio, Milano, Italy, 20033
    Completed
    Bergamo, Bergamo, Italy, 24128
    Completed
    Parma, Parma, Italy, 43100
    Completed
    Bologna, Bologna, Italy, 40138
    Completed
    Martin, Slovakia, 03659
    Completed
    Skalica, Slovakia, 90982
    Completed
    Trencin, Slovakia, 91101
    Completed
    Barcelona, Spain, 8003
    Completed
    Valencia, Spain, 46009
    Completed
    Barcelona, Spain, 8035
    Completed
    Madrid, Spain, 28041
    Completed
    Alcorcon, Madrid, Spain, 28922
    Completed
    St. Petersburg, Russian Federation, 198255
    Completed
    Moscow, Russian Federation, 125101
    Completed
    Moscow, Russian Federation, 115478
    Completed
    St. Petersburg, Russian Federation, 198013
    Completed
    Moscow, Russian Federation, 125284
    Completed
    Milano, Italy
    Completed
    Bari, Italy
    Completed
    Ancona, Italy
    Completed
    Messina, Italy
    Completed
    Chieti, Italy
    Completed
    Granada, Spain
    Completed
    Madrid, Spain
    Completed
    La Coruna, Spain

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?